Research led by Barts Cancer Institute (BCI), Queen Mary University of London, has revealed novel insights into the mechanisms employed by melanoma cells to form tumours at secondary sites around the body. The findings from the study may help to identify new targets to inhibit melanoma spread and guide treatment decisions in the clinic.
The Society for Imaging Informatics in Medicine (SIIM) and the International Skin Imaging Collaboration (ISIC) are working together to host a machine learning challenge on melanoma classification, using the ISIC archive which contains the largest publicly available collection of quality controlled dermoscopic images of skin lesions. Image contributors include: Hospital Clínic de Barcelona,…
Smartphone apps used as ‘early warning systems’ for skin cancer are poorly regulated and frequently cannot be relied upon to produce accurate results, according to new analysis by experts at the University of Birmingham. Skin cancer detection apps are designed to ensure that the right people seek medical attention by providing a risk assessment of a new or changing mole. These apps use…
Skin cancer is the most common cancer in the U.S., affecting one in five Americans in their lifetime. Limiting exposure to ultraviolet radiation is the number one way individuals can reduce their risk of skin cancer, though new data suggests that UV exposure is on the rise, particularly among Caucasian girls and young women. Research presented at the 2019 American Academy of Dermatology Summer…
Researchers have shown for the first time that a form of artificial intelligence or machine learning known as a deep learning convolutional neural network (CNN) is better than experienced dermatologists at detecting skin cancer. In a study published in the leading cancer journal Annals of Oncology, researchers in Germany, the USA and France trained a CNN to identify skin cancer by showing it more…
The long, cold winter, coupled with a rainy spring has most people looking forward to warm sunny days, but too much time in the sun can lead to skin damage and increase the risk of skin cancer, the most common form of cancer in the United States, according to the Centers for Disease Control and Prevention. To raise awareness about the dangers of overexposure to the sun, Robert Wood Johnson…
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous pregnancy with better outcomes after a melanoma diagnosis. Now, a research team from Perelman School of Medicine at the University of Pennsylvania says it may have…
UV radiation has been known for a long time to be a risk factor for the development of skin cancer. Simultaneous infection with human papillomaviruses (HPV) has also been suspected to promote skin cancer, particularly in organ transplant recipients. Scientists from the German Cancer Research Center (DKFZ) have now been able to show for the first time in a natural system that papillomaviruses…
Researchers at Binghamton University, State University of New York have developed a coating made out of DNA that gets better at protecting skin from Ultraviolet light the more it is exposed to the sun and which could potentially be used as wound covering for extreme environments.
Daily tomato consumption appeared to cut the development of skin cancer tumors by half in a mouse study at The Ohio State University. The new study focused on how nutritional interventions can alter the risk for skin cancers.
People with the movement disorder Parkinson’s disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic study finds. Yet the results of the study argue against the Parkinson's drug levodopa as the cause.
A team of researchers has pinpointed a sugar modification in cells that spurs the spread of skin cancer. Its findings spotlight a target in the battle against melanoma.
Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.
Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology. This report researchers from the Swiss Nanoscience Institute, the University of Basel and the University Hospital Basel in first clinical tests with genetic mutations in patients with malignant melanoma.
Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin. It was previously believed that natural killer cells did not have an immunological memory for the body's own tissues. However, the scientists have now showed that these immune cells can indeed…
On March 3, Radiotherapy Group clinicians at Ziekenhuis Gelderse Vallei (Ede, the Netherlands) used their Esteya electronic brachytherapy system for the first time to treat a 73-year-old male patient with a nodular basal cell carcinoma on his nose. Esteya is a form of high dose rate (HDR) brachytherapy that applies high-precision radiotherapy directly to the cancer site, minimizing radiation to…
A number of innovative research results were presented at the 24th Congress of the European Academy of Dermatology and Venereology that took place in Copenhagen from 7 to 11 October 2015. Some of these results are expected to impact medicine far beyond dermatology, demonstrating the innovative character of the specialty.
A team of Tel Aviv University and Harvard Medical School researchers has devised a non-invasive technique that harnesses pulsed electric fields to generate new skin tissue growth. According to their research, the novel non-invasive tissue stimulation technique, utilizing microsecond-pulsed, high-voltage, non-thermal electric fields, produces scarless skin rejuvenation and may revolutionize the…
Universidad Carlos III de Madrid (UC3M) and the Institute for Health Research of the Hospital "Ramón y Cajal" (IRYCIS have patented a new device for performing skin biopsies. With this new tool a skin biopsy can be performed with fewer instruments and the length of the procedure is shortened from thirty minutes to less than five.
In certain types of cancer, nerves and cancer cells enter an often lethal and intricate waltz where cancer cells and nerves move toward one another and eventually engage in such a way that the cancer cells enter the nerves.
With handyscope, FotoFinder presents the first device for mobile skin cancer examination via the iPhone. This digital handheld dermatoscope allows doctors to capture and save microscopic pictures of moles using the iPhone, the handyscope device and the corresponding handyscope app.
For the first time ever, the Nordic country of Sweden will host Europe’s largest dermatology meeting, the 19th Congress of the European Academy of Dermatology and Venereology (EADV), to take place in Gothenburg from 6-10 October, 2010. About 8,000 dermatology specialists - physicians, researchers, and scientists – from all around the globe are expected to participate in the meeting.
An increase in survival in metastatic melanoma – the cancer with the most rapidly increasing incidence across the EU – has been shown for the first time in a major international study by researchers from across Europe. The results showed that patients who received a novel monoclonal antibody called ipilimumab lived 34% longer than control patients given gp100 peptide vaccine.
High-frequency ultrasound with elastography can help differentiate between cancerous and benign skin conditions, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).
The first joint congress ECCO 15 - ESMO 34 of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO) is taking place this week in Berlin. It is the only congress in Europe that covers the entire spectrum of cancer from basic science and translational research, to prevention, treatment, nursing and supportive care for all types of tumours.